DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC
DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC
批准号:
6665871
负责人:
WILLIAM NOWATZKE
金额:
$15.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2003-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Opiates are commonly abused substances, and forensic urine
drug-testing for them involves an immunoassay screen and gas
chromatographic/mass spectrometric (GC/MS) confirmation. There are
also medical reasons to test urine for opiates, and confirmation
procedures other than GC/MS are often used for medical drug-testing
which are more compatible with the demands of clinical services and
which identify a wider range of opiates than those in standard
forensic batteries. One such procedure involves thin-layer
chromatographic (TLC) analysis of opiate derivatives and can
distinguish eight clinically encountered opiates, including morphine,
acetylmorphine, hydromorphone, oxymorphone, codeine, dihydrocodeine,
hydrocodone, and oxycodone. Medical drug-testing results are
sometimes challenged by patients, causing physicians to request
additional confirmation of the identified opiates. To our knowledge,
no previous report examines all opiates specified above in a single
GC/MS pr ocedure, but we find that they can be distinguished by GC/MS
analyses of trimethylsilyl (TMS) ether derivatives, the mass spectra
of which contain prominent molecular ions. Inclusion of
deuterium-labeled internal standards permits quantitation of each of
the eight opiates in urine. The GC/MS assay is linear over a
concentration range which spans the TLC cutoff level, and coefficients
of variation of 10% or less at concentrations below the TLC cutoff are
achieved by for all opiates specified above except for oxymorphone and
oxycodone, which exhibit coefficients of variation of 18-19%. This
procedure has proved useful as a third-stage identification step for
medical drug-testing specimens in which results from prior immunoassay
and TLC analyses were challenged.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MASS SPECTROMETRIC EVIDENCE AGENTS WHICH CAUSE CA2+ LOSS
-
批准号:6665870
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:WILLIAM NOWATZKE
-
依托单位:
MASS SPECTROMETRIC EVIDENCE AGENTS WHICH CAUSE CA2+ LOSS
-
批准号:6486750
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2001
-
负责人:WILLIAM NOWATZKE
-
依托单位:
DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC
-
批准号:6486751
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2001
-
负责人:WILLIAM NOWATZKE
-
依托单位:
MASS SPECTROMETRIC EVIDENCE AGENTS WHICH CAUSE CA2+ LOSS
-
批准号:6336820
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2000
-
负责人:WILLIAM NOWATZKE
-
依托单位:
DISTINCTION AMONG EIGHT OPIATE DRUGS IN URINE BY GAS CHROMATOGRAPHIC
-
批准号:6336821
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2000
-
负责人:WILLIAM NOWATZKE
-
依托单位:
STUDIES OF CA2+ LOSS MECHANISMS IN INTRACELLULAR COMPARTMENTS
-
批准号:6118634
-
项目类别:
-
资助金额:$0.16万
-
财政年份:1998
-
负责人:WILLIAM NOWATZKE
-
依托单位: